Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vaccine Administration Rates”

7 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 7 of 7 results

Not applicableWithdrawnNCT03123419
What this trial is testing

Gardasil Administration

Who this might be right for
Vaccine Administration Rates
St. Louis University
Not applicableStudy completedNCT05993260
What this trial is testing

Using Text Messages to Boost COVID-19 Vaccine Booking Rate

Who this might be right for
Vaccination HesitancyCOVID-19
The Behavioural Insights Team 1,825,937
Not applicableUnknownNCT06237374
What this trial is testing

Supporting CHWs as Vaccine Educators: Impact of a Digital Training and Chatbot Intervention on Vaccination in Kenya

Who this might be right for
Vaccine KnowledgeVaccine HesitancyVaccine Refusal
Stanford University 795
Not applicableStudy completedNCT02266277
What this trial is testing

System Alignment for VaccinE Delivery (SAVED): Improving Rates of Influenza and Pneumococcal Vaccination Through Patient Outreach, Improved Medical Record Accuracy and Targeted Physician Alerts

Who this might be right for
InfluenzaInfections, Pneumococcal
University of Massachusetts, Worcester 30,000
Not applicableUnknownNCT05891626
What this trial is testing

Group Intervention on Vaccine Confidence

Who this might be right for
Vaccination Refusal
MultiCare Health System Research Institute 429
Testing effectiveness (Phase 2)Study completedNCT03702231
What this trial is testing

Response to the SHINGRIX Varicella Zoster Virus (VZV) Vaccine in Chronic Lymphocytic Leukemia (CLL) and CLL Treated With Bruton's Tyrosine Kinase Inhibitor (BTK-I)

Who this might be right for
Safety and TolerabilityCompare SHINGRIX Vaccine Response RatesChronic Lymphocytic Leukemia (CLL)+1 more
National Heart, Lung, and Blood Institute (NHLBI) 116
Not applicableStudy completedNCT04568590
What this trial is testing

Promoting Altruism to Enhance Vaccine Acceptance

Who this might be right for
Vaccine Refusal
Wake Forest University Health Sciences 510